Mohan Patil is a PhD scholar at Curtin Health Innovation Research Institute (CHIRI), Perth (Western Australia). He completed his Masters in Pharmacology (M.Pharm.) from JSS University, India. Mohan has an industrial drug discovery research experience in the metabolic disorders domain. During his previous industrial assignments, he served as a professional in-vivo pharmacologist for developing small-molecule and peptide-based therapies to treat diabetes and obesity.